Thursday Mar 28, 2024
Thursday Mar 28, 2024

Sinovac: CoronaVac vaccine effective in children


Nepalnews
2021 Mar 23, 11:25, BEIJING
In this December 23, 2020, file photo released by China's Xinhua News Agency, a Sinovac worker checks the labelling on vials of COVID-19 vaccines on a packaging line in Beijing. With just four of China’s many vaccine makers claiming they are able to produce at least 2.6 billion doses this year, a large part of the world’s population will end up inoculated not with western vaccines boasting headline-grabbing efficacy rates, but with China’s traditionally made shots. (Photo via AP)

Sinovac said on Monday that its COVID-19 vaccine CoronaVac is safe and effective in children ages 3-17.

The results were from early and mid-stage clinical trials with over 550 subjects, said Geng Zeng, the medical director at Sinovac, at a press conference.

While the vaccine has already been allowed for use in adults in China, further testing was needed to see how it would work with children.

More than 70 million shots of Sinovac’s vaccine has been given worldwide, including in China.

There were two instances of high fevers in response to the vaccine during trials, one in a 3-year old participant and the other in a six-year old. The rest of the participants had experienced mild symptoms, said Geng.

State-owned Sinopharm, who has two COVID-19 vaccines, is also investigating the effectiveness of its vaccines in children. They had said in January that they submitted clinical data to regulators, though it was unclear if it was for both of their shots or just one.

READ ALSO:

Sinovac. covid-19 Vaccine CoronaVac clinical trials china
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

KMC-02, UttarDhoka,
Lazimpat, Nepal

Newsroom
+977–01–4445751 / 4445754

E-mail
[email protected] [email protected]

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal